Systemic Inflammatory Patterns in Ovarian Cancer Patients: Analysis of Cytokines, Chemokines, and Microparticles
Revista Brasileira de Ginecologia e Obstetricia, ISSN: 0100-7203, Vol: 45, Issue: 12, Page: E780-E789
2023
- 4Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Most Recent News
Reports Outline Epithelial Ovarian Cancer Study Findings from State University Paulista (Systemic Inflammatory Patterns in Ovarian Cancer Patients: Analysis of Cytokines, Chemokines, and Microparticles)
2024 JAN 09 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Women's Health Daily -- Investigators discuss new findings in epithelial ovarian cancer.
Article Description
Objective ?To compare the patterns of systemic inflammatory response in women with epithelial ovarian cancer (EOC) or no evidence of malignant disease, as well as to evaluate the profile of systemic inflammatory responses in type-1 and type-2 tumors. This is a non-invasive and indirect way to assess both tumor activity and the role of the inflammatory pattern during pro- and antitumor responses. Materials and Methods ?We performed a prospective evaluation of 56 patients: 30 women without evidence of malignant disease and 26 women with EOC. The plasma quantification of cytokines, chemokines, and microparticles (MPs) was performed using flow cytometry. Results ?Plasma levels of proinflammatory cytokines interleukin-12 (IL12), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α) interleukin-1 beta (IL-1β), and interleukin-10 (IL-10), and C-X-C motif chemokine ligand 9 (CXCL-9) and C-X-C motif chemokine ligand 10 (CXCL-10) were significantly higher in patients with EOC than in those in the control group. Plasma levels of cytokine interleukin-17A (IL-17A) and MPs derived from endothelial cells were lower in patients with EOC than in the control group. The frequency of leukocytes and MPs derived from endothelial cells was higher in type-2 tumors than in those without malignancy. We observed an expressive number of inflammatory/regulatory cytokines and chemokines in the cases of EOC, as well as negative and positive correlations involving them, which leads to a higher complexity of these networks. Conclusion ?The present study showed that, through the development of networks consisting of cytokines, chemokines, and MPs, there is a greater systemic inflammatory response in patients with EOC and a more complex correlation of these biomarkers in type-2 tumors.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85181177567&origin=inward; http://dx.doi.org/10.1055/s-0043-1772590; http://www.ncbi.nlm.nih.gov/pubmed/38141599; https://journalrbgo.org/article/systemic-inflammatory-patterns-in-ovarian-cancer-patients-analysis-of-cytokines-chemokines-and-microparticles/; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032023001200780&lng=en&tlng=en; http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0100-72032023001200780&lng=en&tlng=en; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032023001200780; http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0100-72032023001200780; https://dx.doi.org/10.1055/s-0043-1772590
Federação das Associações de Ginecologia e Obstetrícia
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know